Higher serum calretinin concentration was associated with shorter PFS (HR = 1.18, 95% CI = 1.02–1.37, p = 0.023) and shorter OS in MM patients (HR = 1.20, 95% CI = 1.03–1.41, p = 0.023). This evidence concerns the gene CALB2 and Miyoshi myopathy.